Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, May 8, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Venture Capital
Omega Funds Closes $647 Million Oversubscribed Fund to Back Life Sciences Innovation
Life Sciences Times
-
July 21, 2025
0
People on the Move
BBOT Names Uneek Mehra as Chief Financial Officer to Support Growth and Oncology Pipeline Expansion
Life Sciences Times
-
July 21, 2025
0
People on the Move
DeciBio Consulting Promotes Carl Schoellhammer to Partner, Bolstering Leadership in Advanced Therapies and Strategic Investment
Life Sciences Times
-
July 21, 2025
0
Pharma
TAGRISSO Plus Chemotherapy Significantly Improves Survival in Advanced EGFR-Mutated Lung Cancer, AstraZeneca Reports
Life Sciences Times
-
July 21, 2025
0
Medtech
FDA Clears Takeda’s HyHub and HyHub Duo Devices to Simplify HYQVIA Administration
Life Sciences Times
-
July 21, 2025
0
Pharma
Cycle Pharmaceuticals Taps LeMed as Exclusive U.S. Specialty Pharmacy Partner for New AKU Treatment
Life Sciences Times
-
July 21, 2025
0
Healthcare
CareDx Welcomes Draft Medicare Policy Supporting Continued Coverage of Transplant Surveillance Testing
Life Sciences Times
-
July 18, 2025
0
Medtech
Kerecis Honored with Premier Sustainability Award for Cutting Greenhouse Gas Emissions
Life Sciences Times
-
July 18, 2025
0
Real Estate
GenesisM Breaks Ground on 154,000-Square-Foot Biomanufacturing Facility in Bedford
Life Sciences Times
-
July 18, 2025
0
Technology
Sensome Technology Enables Breakthrough in Real-Time Cancer Monitoring, Study Finds
Life Sciences Times
-
July 17, 2025
0
1
...
146
147
148
...
836
Page 147 of 836
Most Popular
WHOOP Expands Health Platform With Clinician Access and AI Features
May 8, 2026
Reprieve Cardiovascular Reports Published Pilot Trial Results for Heart Failure Therapy
May 8, 2026
Stoke Therapeutics Advances Dravet Syndrome Drug as Phase 3 Study Nears Enrollment Goal
May 8, 2026
Myomo Revenue Rises as Company Expands Recurring Patient Sources
May 8, 2026
Load more
Recent Comments
Recent Comments